2025-03-11 22:17:06
Latest Post
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Hexaware Inaugurates Global Business Headquarters in Jersey City
HCLTech among Ethisphere's 2025 World's Most Ethical Companies®
Ind-Swift Laboratories Ltd receives 'Best Employer Brand - Punjab 2025' by World HRD Congress
Stock Report
Advanced Enzyme Technologies posts Rs. 27.48 crores consolidated PAT in Q3 FY22
Posted On : 2022-02-05 12:44:22( TIMEZONE : IST )
Advanced Enzyme Technologies Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 134.764 crores during the period ended December 31, 2021 as compared to Rs. 127.976 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 27.484 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 29.698 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 2.45 for the period ended December 31, 2021 as compared to Rs. 2.65 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 134.764 crs | ₹127.976 crs |  5.30% |
| Net Profit | ₹27.484 crs | ₹29.698 crs |  -7.46% |
| EPS | ₹2.45 | ₹2.65 | -7.55% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 134.764 crores during the period ended December 31, 2021 as compared to Rs.139.086 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.27.484 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.43.088 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.2.45 for the period ended December 31, 2021 as compared to Rs.3.85 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 134.764 crs | ₹139.086 crs | -3.11% |
| Net Profit | ₹27.484 crs | ₹43.088 crs | -36.21% |
| EPS | ₹2.45 | ₹3.85 | -36.36% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.400.687 crores during the 9 Months period ended December 31, 2021 as compared to Rs.375.789 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.95.150 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.114.522 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.8.50 for the 9 Months period ended December 31, 2021 as compared to Rs.10.24 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹400.687 crs | ₹375.789 crs | 6.63% |
| Net Profit | ₹95.150 crs | ₹114.522 crs | -16.92% |
| EPS | ₹8.50 | ₹10.24 | -16.99% |
Shares of Advanced Enzyme Technologies Limited was last trading in BSE at Rs. 340.45 as compared to the previous close of Rs. 348.00. The total number of shares traded during the day was 6749 in over 521 trades.
The stock hit an intraday high of Rs. 355.15 and intraday low of 338.35. The net turnover during the day was Rs. 2308439.00.
